|
EP1693804B1
(en)
*
|
1996-09-04 |
2009-11-11 |
Intertrust Technologies Corp. |
Trusted infrastructure support systems, methods and techniques for secure electronic commerce, electronic transactions, commerce process control and automation, distributed computing and rights management
|
|
CN101511840A
(zh)
|
2006-04-26 |
2009-08-19 |
吉宁特有限公司 |
磷酸肌醇3-激酶抑制剂化合物及其使用方法
|
|
TWI498332B
(zh)
*
|
2006-04-26 |
2015-09-01 |
Hoffmann La Roche |
作為pi3k抑制劑之嘧啶衍生物及相關製備方法、醫藥組合物、用途、套組及產物
|
|
ES2571028T3
(es)
*
|
2006-12-07 |
2016-05-23 |
Genentech Inc |
Compuestos inhibidores de fosfoinositida 3-cinasa y métodos de uso
|
|
WO2008070740A1
(en)
*
|
2006-12-07 |
2008-06-12 |
F.Hoffmann-La Roche Ag |
Phosphoinositide 3-kinase inhibitor compounds and methods of use
|
|
US9370508B2
(en)
*
|
2007-02-20 |
2016-06-21 |
Novartis Ag |
Imidazoquinolines as dual lipid kinase and mTOR inhibitors
|
|
US7893060B2
(en)
*
|
2007-06-12 |
2011-02-22 |
F. Hoffmann-La Roche Ag |
Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
|
|
AU2008298948B2
(en)
*
|
2007-09-12 |
2014-09-04 |
F. Hoffmann-La Roche Ag |
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use
|
|
WO2009042607A1
(en)
*
|
2007-09-24 |
2009-04-02 |
Genentech, Inc. |
Thiazolopyrimidine p13k inhibitor compounds and methods of use
|
|
US8354528B2
(en)
|
2007-10-25 |
2013-01-15 |
Genentech, Inc. |
Process for making thienopyrimidine compounds
|
|
GB0721095D0
(en)
*
|
2007-10-26 |
2007-12-05 |
Piramed Ltd |
Pharmaceutical compounds
|
|
CN101835779B
(zh)
*
|
2007-10-26 |
2014-01-29 |
霍夫曼-拉罗奇有限公司 |
作为pi3激酶抑制剂的嘌呤衍生物
|
|
AU2009246053B2
(en)
|
2008-05-14 |
2014-07-24 |
Agriculture Victoria Services Pty Ltd. |
Use of angiogenin or angiogenin agonists for treating diseases and disorders
|
|
JP2011521968A
(ja)
*
|
2008-05-30 |
2011-07-28 |
ジェネンテック， インコーポレイテッド |
プリンｐｉ３ｋ阻害剤化合物および使用方法
|
|
AR073354A1
(es)
*
|
2008-07-31 |
2010-11-03 |
Genentech Inc |
Compuestos de pirimidina, composiciones farmaceuticas y su uso en el tratamiento del cancer.
|
|
TWI378933B
(en)
|
2008-10-14 |
2012-12-11 |
Daiichi Sankyo Co Ltd |
Morpholinopurine derivatives
|
|
NZ592748A
(en)
|
2008-10-17 |
2013-01-25 |
Akaal Pharma Pty Ltd |
2-Amino-(oxadiazol-3-yl)-benzofuran derivatives and their use as S1P receptor modulators
|
|
WO2010042998A1
(en)
|
2008-10-17 |
2010-04-22 |
Akaal Pharma Pty Ltd |
S1p receptors modulators
|
|
US8586582B2
(en)
|
2008-11-11 |
2013-11-19 |
Xcovery Holding Company, Llc |
PI3K/mTOR kinase inhibitors
|
|
US8653098B2
(en)
|
2008-11-20 |
2014-02-18 |
Genentech, Inc. |
Pyrazolopyridine PI3K inhibitor compounds and methods of use
|
|
SI2373640T1
(sl)
|
2009-01-08 |
2014-11-28 |
Merck Patent Gmbh |
Nove polimorfne oblike hidrokloridne soli 3-(1-(3-(5-(1-metil-piperidin-4ilmetoksi)-pirimidin-2-il)-benzil)-6- okso-1,6-dihidro-piridazin-3-il)-benzonitrila in postopki proizvodnje le-teh
|
|
AU2010203512C1
(en)
|
2009-01-08 |
2013-10-17 |
Curis, Inc. |
Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
|
|
CN102369011A
(zh)
|
2009-03-12 |
2012-03-07 |
健泰科生物技术公司 |
用于治疗造血恶性肿瘤的磷酸肌醇3-激酶抑制剂化合物与化学治疗剂的组合
|
|
ES2665277T3
(es)
*
|
2009-03-13 |
2018-04-25 |
Katholieke Universiteit Leuven K.U. Leuven R&D |
Análogos de purina y su uso como agentes inmunosupresores
|
|
CN102361878A
(zh)
|
2009-03-24 |
2012-02-22 |
住友化学株式会社 |
用于制备硼酸酯化合物的方法
|
|
SG174527A1
(en)
|
2009-03-27 |
2011-11-28 |
Pathway Therapeutics Inc |
Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
|
|
CA2772371A1
(en)
|
2009-05-27 |
2010-12-02 |
F. Hoffmann-La Roche Ag |
Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
|
|
CN102459272B
(zh)
*
|
2009-05-27 |
2014-08-06 |
健泰科生物技术公司 |
对P110δ具有选择性的为PI3K抑制剂的二环嘧啶化合物和使用方法
|
|
SG176959A1
(en)
*
|
2009-06-24 |
2012-01-30 |
Genentech Inc |
Oxo-heterocycle fused pyrimidine compounds, compositions and methods of use
|
|
US8486939B2
(en)
|
2009-07-07 |
2013-07-16 |
Pathway Therapeutics Inc. |
Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
|
|
WO2011017520A1
(en)
*
|
2009-08-05 |
2011-02-10 |
Wake Forest University Health Sciences |
Compositions and methods for inducing apoptosis in prostate cancer cells
|
|
PE20121148A1
(es)
|
2009-08-17 |
2012-09-07 |
Intellikine Llc |
Compuestos heterociclicos y usos de los mismos
|
|
IN2012DN01325A
(https=)
*
|
2009-08-20 |
2015-06-05 |
Karus Therapeutics Ltd |
|
|
EP2475375A4
(en)
*
|
2009-09-09 |
2013-02-20 |
Avila Therapeutics Inc |
PI3 KINASE INHIBITORS AND USES THEREOF
|
|
EP2475367A1
(en)
*
|
2009-09-10 |
2012-07-18 |
Centre National De La Recherche Scientifique |
NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES
|
|
ES2558742T3
(es)
|
2009-09-28 |
2016-02-08 |
F. Hoffmann-La Roche Ag |
Compuestos inhibidores de PI3K de benzoxepina y métodos de uso
|
|
WO2011049625A1
(en)
|
2009-10-20 |
2011-04-28 |
Mansour Samadpour |
Method for aflatoxin screening of products
|
|
PH12012500901A1
(en)
|
2009-11-05 |
2016-08-05 |
Rhizen Pharmaceuticals Sa |
Novel benzopyran kinase modulators
|
|
CN102712642B
(zh)
*
|
2009-11-12 |
2015-08-12 |
霍夫曼-拉罗奇有限公司 |
N-7取代的嘌呤和吡唑并嘧啶化合物、组合物和使用方法
|
|
WO2011058027A2
(en)
*
|
2009-11-12 |
2011-05-19 |
F. Hoffmann-La Roche Ag |
N-9-substituted purine compounds, compositions and methods of use
|
|
US8633183B2
(en)
*
|
2010-01-26 |
2014-01-21 |
Boehringer Ingelheim International Gmbh |
5-alkynyl-pyrimidines
|
|
MX2012009059A
(es)
|
2010-02-22 |
2012-09-07 |
Hoffmann La Roche |
Compuestos inhibidores de fosfoinositida 3-cinasa delta (pi3k) pirido [3,2-d]pirimidina y metodos de uso.
|
|
UY33304A
(es)
*
|
2010-04-02 |
2011-10-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
|
JP5555378B2
(ja)
|
2010-07-14 |
2014-07-23 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｐｉ３ｋｐ１１０デルタに選択的なプリン化合物とその使用の方法
|
|
CN103313989B
(zh)
|
2010-12-16 |
2016-05-04 |
霍夫曼-拉罗奇有限公司 |
三环pi3k抑制剂化合物和使用方法
|
|
CA2825825A1
(en)
*
|
2011-01-27 |
2012-08-02 |
The Trustees Of Princeton University |
Inhibitors of mtor kinase as anti-viral agents
|
|
CA2825028A1
(en)
|
2011-02-09 |
2012-08-16 |
F. Hoffman-La Roche Ag |
Heterocyclic compounds as pi3 kinase inhibitors
|
|
WO2012126901A1
(en)
|
2011-03-21 |
2012-09-27 |
F. Hoffmann-La Roche Ag |
Benzoxazepin compounds selective for pi3k p110 delta and methods of use
|
|
ES2608967T3
(es)
|
2011-03-28 |
2017-04-17 |
Mei Pharma, Inc. |
(Aralquilamino sustituido en alfa y heteroarilalquilamino)pirimidinil y 1,3,5-triazinil benzimidazoles, composiciones farmacéuticas que los contienen, y estos compuestos para usar en el tratamiento de enfermedades proliferativas
|
|
DK3111938T3
(da)
|
2011-04-01 |
2019-07-01 |
Curis Inc |
Phosphoinositid 3-kinase-hæmmer med en zink-bindende gruppe
|
|
HRP20190128T1
(hr)
|
2011-05-04 |
2019-03-08 |
Rhizen Pharmaceuticals S.A. |
Novi spojevi kao modulatori protein kinaza
|
|
EP2524918A1
(en)
|
2011-05-19 |
2012-11-21 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyrazines derivates as kinase inhibitors
|
|
KR101255939B1
(ko)
*
|
2011-05-31 |
2013-04-23 |
동화약품주식회사 |
4-(1ｈ-인다졸-6-일아미노)-ｎ-아이소프로필-2-(메틸티오)피리미딘-5-카르복스아미드 화합물 또는 이의 약학적으로 허용가능한 염을 포함하는 당뇨병 예방 또는 치료용 조성물
|
|
CA2849331A1
(en)
*
|
2011-10-13 |
2013-04-18 |
Genentech, Inc. |
Treatment of pharmacological-induced hypochlorhydria
|
|
HK1202333A1
(en)
*
|
2011-11-11 |
2015-09-25 |
Intellikine, Llc |
Combination of kinase inhibitors and uses thereof
|
|
CN102643272B
(zh)
*
|
2011-12-30 |
2015-03-11 |
沈阳药科大学 |
新的噻吩并[3,2-d]嘧啶类化合物
|
|
GB201204125D0
(en)
|
2012-03-08 |
2012-04-25 |
Karus Therapeutics Ltd |
Compounds
|
|
FR2988722B1
(fr)
|
2012-04-03 |
2014-05-09 |
Sanofi Sa |
Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques
|
|
CN103467482B
(zh)
|
2012-04-10 |
2017-05-10 |
上海璎黎药业有限公司 |
稠合嘧啶类化合物，其制备方法，中间体，组合物和应用
|
|
DK2838533T3
(da)
|
2012-04-16 |
2017-11-27 |
Univ Case Western Reserve |
Sammensætninger og fremgangsmåder til at modulere 15-pgdh-aktivitet
|
|
US9801863B2
(en)
|
2012-04-16 |
2017-10-31 |
Case Western Reserve University |
Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
|
|
CA2872002C
(en)
*
|
2012-05-07 |
2019-01-15 |
Masayuki Isaji |
Pyrazole derivative and use thereof for medical purposes
|
|
AU2013204740C1
(en)
|
2012-05-10 |
2015-10-01 |
Agriculture Victoria Services Pty Ltd |
Methods of treating cancer using angiogenin or an angiogenin agonist
|
|
JP6301316B2
(ja)
|
2012-05-23 |
2018-03-28 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
内胚葉細胞および肝実質細胞の組成物ならびにそれらの細胞を入手および使用する方法
|
|
WO2013182668A1
(en)
|
2012-06-08 |
2013-12-12 |
F. Hoffmann-La Roche Ag |
Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
|
|
CN109970742A
(zh)
|
2012-07-04 |
2019-07-05 |
理森制药股份公司 |
选择性PI3Kδ抑制剂
|
|
MX361157B
(es)
*
|
2012-08-30 |
2018-11-28 |
Hoffmann La Roche |
Compuestos inhibidores de pi3k de dioxino- y oxazin-[2,3-d]pirimid ina y métodos de uso.
|
|
US20150258127A1
(en)
|
2012-10-31 |
2015-09-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for preventing antiphospholipid syndrome (aps)
|
|
JP6329958B2
(ja)
|
2012-11-07 |
2018-05-23 |
カルス セラピューティクス リミテッド |
新規ヒストンデアセチラーゼインヒビターおよび治療におけるその使用
|
|
EP2984088B1
(en)
*
|
2013-04-12 |
2019-03-20 |
Asana BioSciences, LLC |
Quinazolines and azaquinazolines as dual inhibitors of ras/raf/mek/erk and pi3k/akt/pten/mtor pathways
|
|
NZ714283A
(en)
|
2013-05-10 |
2020-04-24 |
Karus Therapeutics Ltd |
Novel histone deacetylase inhibitors
|
|
DE102013008118A1
(de)
*
|
2013-05-11 |
2014-11-13 |
Merck Patent Gmbh |
Arylchinazoline
|
|
WO2014203129A1
(en)
|
2013-06-19 |
2014-12-24 |
Olema Pharmaceuticals, Inc. |
Combinations of benzopyran compounds, compositions and uses thereof
|
|
US9745321B2
(en)
|
2013-09-30 |
2017-08-29 |
Shanghai Yingli Pharmaceutical Co., Ltd |
Fused pyrimidine compound, intermediate, preparation method therefor, and composition and application thereof
|
|
AU2014342811B2
(en)
|
2013-10-15 |
2019-01-03 |
Board Of Regents Of The University Of Texas System |
Compositions and methods of modulating short-chain dehydrogenase activity
|
|
NZ718487A
(en)
|
2013-10-16 |
2020-01-31 |
Shanghai Yingli Pharm Co Ltd |
Fused heterocyclic compound, preparation method therefor, pharmaceutical composition, and uses thereof
|
|
EP3102569A1
(en)
|
2014-02-06 |
2016-12-14 |
AbbVie Inc. |
6-heteroaryloxy- and 6-aryloxy-quinoline-2-carboxamides and uses thereof
|
|
GB201402431D0
(en)
|
2014-02-12 |
2014-03-26 |
Karus Therapeutics Ltd |
Compounds
|
|
GB201419228D0
(en)
|
2014-10-29 |
2014-12-10 |
Karus Therapeutics Ltd |
Compounds
|
|
GB201419264D0
(en)
|
2014-10-29 |
2014-12-10 |
Karus Therapeutics Ltd |
Compounds
|
|
CN118059093A
(zh)
|
2015-03-08 |
2024-05-24 |
卡斯西部储备大学 |
用于治疗纤维症的短链脱氢酶活性的抑制剂
|
|
US20180057505A1
(en)
*
|
2015-03-20 |
2018-03-01 |
Vertex Pharmaceuticals Incorporated |
Bicyclic heteroaryl compounds useful as inhibitors of the par-2 signaling pathway
|
|
AR104068A1
(es)
|
2015-03-26 |
2017-06-21 |
Hoffmann La Roche |
Combinaciones de un compuesto inhibidor de fosfoinosítido 3-cinasa y un compuesto inhibidor de cdk4/6 para el tratamiento del cáncer
|
|
ES2733505T3
(es)
*
|
2015-03-30 |
2019-11-29 |
Daiichi Sankyo Co Ltd |
Derivados de 6-morfolinil-2-pirazolil-9H-purina y su uso como inhibidores PI3K
|
|
JP2018511616A
(ja)
*
|
2015-04-14 |
2018-04-26 |
ケース ウエスタン リザーブ ユニバーシティ |
短鎖デヒドロゲナーゼ活性を調節する組成物および方法
|
|
HK1249866A1
(zh)
|
2015-06-29 |
2018-11-16 |
豪夫迈‧罗氏有限公司 |
用他塞利昔布进行治疗的方法
|
|
GB201514760D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Compounds and method of use
|
|
GB201514751D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Compounds
|
|
GB201514758D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Formulation
|
|
GB201514754D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Compounds
|
|
JP7114076B2
(ja)
|
2015-12-22 |
2022-08-08 |
シャイ・セラピューティクス・エルエルシー |
がん及び炎症性疾患の処置のための化合物
|
|
CN107098846B
(zh)
*
|
2016-02-26 |
2020-10-09 |
中国医学科学院药物研究所 |
N-酰基磺酰胺类FBPase抑制剂、其制备方法、药物组合物及用途
|
|
WO2017197151A1
(en)
|
2016-05-11 |
2017-11-16 |
Emory University |
Phosphotidylinositol 3-kinase inhibitors
|
|
MY199070A
(en)
|
2016-06-01 |
2023-10-12 |
Bayer Pharma AG |
Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseaes in animals
|
|
WO2018057588A1
(en)
*
|
2016-09-21 |
2018-03-29 |
Vertex Pharmaceuticals Incorporated |
Furo[3,2-b]pyridine compounds useful as inhibitors of the par-2 signaling pathway
|
|
TW201813963A
(zh)
|
2016-09-23 |
2018-04-16 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
TW201815787A
(zh)
|
2016-09-23 |
2018-05-01 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
TW201825465A
(zh)
|
2016-09-23 |
2018-07-16 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
US11304953B2
(en)
|
2017-05-23 |
2022-04-19 |
Mei Pharma, Inc. |
Combination therapy
|
|
JP7514005B2
(ja)
|
2017-06-21 |
2024-07-10 |
シャイ・セラピューティクス・エルエルシー |
がん、炎症性疾患、ラソパシー、及び線維性疾患の治療のためのｒａｓスーパーファミリーと相互作用する化合物
|
|
KR20200041358A
(ko)
|
2017-08-14 |
2020-04-21 |
메이 파마, 아이엔씨. |
병용 요법
|
|
CN109796465B
(zh)
*
|
2017-11-16 |
2020-07-14 |
华中科技大学同济医学院附属协和医院 |
靶向pet显像化合物、包含该化合物的显象剂及其制备方法和用途
|
|
CN113194752A
(zh)
|
2018-06-01 |
2021-07-30 |
康奈尔大学 |
Pi3k相关疾病或病症的组合疗法
|
|
SG11202102343QA
(en)
|
2018-09-11 |
2021-04-29 |
Curis Inc |
Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety
|
|
CA3154278A1
(en)
*
|
2018-10-12 |
2020-04-16 |
Corey Hopkins |
Phosphodiesterase inhibitors
|
|
JP7407461B2
(ja)
|
2018-12-19 |
2024-01-04 |
シャイ・セラピューティクス・エルエルシー |
がん、炎症性疾患、ｒａｓ病、及び線維性疾患の処置のためのｒａｓスーパーファミリーと相互作用する化合物
|
|
GB201909468D0
(en)
|
2019-07-01 |
2019-08-14 |
Karus Therapeutics Ltd |
Compounds for treating cancer
|
|
KR20220140515A
(ko)
|
2020-01-13 |
2022-10-18 |
버지 애널리틱스, 인크. |
치환된 피라졸로-피리미딘 및 그의 용도
|
|
EP4161519A4
(en)
*
|
2020-06-03 |
2024-07-17 |
Yumanity Therapeutics, Inc. |
PURINES AND METHODS OF USE
|
|
JP7675182B2
(ja)
*
|
2020-11-10 |
2025-05-12 |
フォグホーン セラピューティクス インコーポレイテッド |
化合物及びその使用
|
|
EP4303216A1
(en)
*
|
2021-03-03 |
2024-01-10 |
Genfleet Therapeutics (Shanghai) Inc. |
Fused ring substituted six-membered heterocyclic compound, preparation method therefor and use thereof
|
|
US20240226126A1
(en)
*
|
2021-06-16 |
2024-07-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions for treatment of psoriasis
|
|
WO2022268025A1
(zh)
*
|
2021-06-22 |
2022-12-29 |
成都苑东生物制药股份有限公司 |
Atr抑制剂及其用途
|
|
US20250042914A1
(en)
*
|
2021-09-30 |
2025-02-06 |
Hanmi Pharm. Co., Ltd. |
Pikfyve kinase inhibitor
|
|
CN115991716B
(zh)
*
|
2021-10-19 |
2025-10-17 |
中国药科大学 |
嘧啶并环类化合物及其衍生物、制备方法、药物组合物和应用
|
|
CN118488947A
(zh)
*
|
2022-01-04 |
2024-08-13 |
劲方医药科技(上海)有限公司 |
稠环取代的六元杂环化合物及其制法和用途
|
|
CN114539293B
(zh)
*
|
2022-02-24 |
2023-09-22 |
广东晨康生物科技有限公司 |
一种噻吩并嘧啶类化合物或其药学上可接受的盐及其制备方法和应用
|
|
AR129299A1
(es)
|
2022-05-11 |
2024-08-07 |
Foghorn Therapeutics Inc |
Compuestos para modular complejos de factores asociados a brg1 o brm (baf)
|
|
CN117164590B
(zh)
*
|
2022-05-25 |
2026-03-17 |
沈阳药科大学 |
稠合嘧啶类衍生物及其应用
|
|
TW202432114A
(zh)
*
|
2022-10-26 |
2024-08-16 |
德商百靈佳殷格翰國際股份有限公司 |
可活化sting之雜環化合物
|